KALA BIO Inc
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
KALA$0.18+13.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Exhibit Index
| EXHIBIT 3.1 | | Restated Certificate of Incorporation of the Registrant, as amended as of November 28, 2022, including Certificate of Designation of the Series D Preferred Stock of Registrant, Certificate of Elimination of Number of Shares of Preferred Stock Designated as Series D Preferred Stock of Registrant, Certificate of Designations, Preferences and Rights of Series E Convertible Non-Redeemable Preferred Stock of Registrant, Certificate of Designations, Preferences and Rights of Series F Convertible Non-Redeemable Preferred Stock of Registrant and Certificate of Designations, Preferences and Rights of Series G Convertible Non-Redeemable Preferred Stock of Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s annual report on Form 10-K (File No. 001-38150) filed on March 29, 2024) |
|---|---|---|
| | | |
| EXHIBIT 4.1 | | Form of Series G Preferred Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s current report on Form 8-K (File No. 001-38150) filed on March 26, 2024) |
| | | |
| EXHIBIT 10.1 | | Securities Purchase Agreement, dated March 25, 2024, by and among the Registrant and the purchasers party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s current report on Form 8-K (File No. 001-38150) filed on March 26, 2024) |
| | | |
| EXHIBIT 31.1+ | - | Certification of Chief Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | | |
| EXHIBIT 31.2+ | - | Certification of Chief Financial Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | | |
| EXHIBIT 32.1++ | - | Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, by Mark Iwicki, Chief Executive Officer of the Company. |
| | | |
| EXHIBIT 32.2++ | - | Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, by Mary Reumuth, Chief Financial Officer of the Company. |
| | | |
| EXHIBIT 101.INS | - | Inline XBRL Instance Document. (the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document) |
| | | |
| EXHIBIT 101.SCH | - | Inline XBRL Taxonomy Extension Schema Document. |
| | | |
| EXHIBIT 101.CAL | - | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| | | |
| EXHIBIT 101.DEF | - | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| | | |
| EXHIBIT 101.LAB | - | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| | | |
| EXHIBIT 101.PRE | - | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| | | |
|---|---|---|
| EXHIBIT 104 | - | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101). |
- Filed herewith
++ Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.